- Home
- NXPI vs EW Comparison
NXPI vs EW Comparison
Compare NXPI & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXPI | EW |
|---|---|---|
| Founded | 2006 | 1958 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8B | 49.5B |
| IPO Year | 2010 | 2000 |
Fundamental Metrics
Financial Performance| Metric | NXPI | EW |
|---|---|---|
| Price | $239.00 | $84.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 21 |
| Target Price | ★ $246.00 | $96.37 |
| AVG Volume (30 Days) | 2.7M | ★ 3.1M |
| Earning Date | 02-02-2026 | 02-10-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 8.08 | 2.33 |
| Revenue | ★ $12,045,000,000.00 | $5,883,800,000.00 |
| Revenue This Year | N/A | $14.29 |
| Revenue Next Year | $9.06 | $9.68 |
| P/E Ratio | ★ $29.33 | $36.90 |
| Revenue Growth | N/A | ★ 10.60 |
| 52 Week Low | $148.09 | $65.94 |
| 52 Week High | $255.45 | $87.89 |
Technical Indicators
Market Signals| Indicator | NXPI | EW |
|---|---|---|
| Relative Strength Index (RSI) | 60.23 | 48.32 |
| Support Level | $235.33 | $81.26 |
| Resistance Level | $243.46 | $86.10 |
| Average True Range (ATR) | 6.42 | 1.74 |
| MACD | 0.37 | -0.22 |
| Stochastic Oscillator | 73.78 | 48.87 |
Price Performance
Historical ComparisonAbout NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.